Oncology Manager at Abbott

Lima, Callao Region, Peru

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Licenciatura
10 years of experience in the pharmaceutical or biotechnology industry, with specialization in biological/biosimilar products (3 years)
Demonstrable experience in market access roles, including development and implementation of strategies
Experience in interdisciplinary leadership, collaborating with various departments (e.g., marketing, sales, regulation)
Demonstrated ability to interact and build relationships with stakeholders

Responsibilities

Strengthen Abbott's positioning and differentiation in the oncology market
Implement initiatives to improve patient access to chemical, biological, and biosimilar products, addressing affordability and availability in the healthcare system
Establish and foster relationships with key stakeholders, including healthcare professionals and legislators
Leverage market research and data analysis to support strategic decisions and optimize product offerings
Drive innovative approaches for biosimilars to keep Abbott at the forefront of the industry
Align biosimilars strategy with Abbott's broader corporate objectives to enhance regional growth and profitability
Manage the Oncology Business Unit (BUM) to better understand and navigate the complexities of the Peruvian healthcare environment and capitalize on biosimilars market opportunities

Skills

Market Research

Data Analysis

Stakeholder Management

Strategic Planning

Leadership

Biosimilars

Oncology

Healthcare Policy

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free